Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „ticagrelor“
Suchtreffer
Begriffe & Kennungen
Brilique · 4.8 · Compared with clopidogrel, patients with asthma/COPD treated with ticagrelor may have an increased risk of exp
Eintrag öffnenBrilique · 4.8 · Compared with clopidogrel, patients with asthma/COPD treated with ticagrelor may have an increased risk of exp
Eintrag öffnenBrilique · 4.8 · Dyspnoea Dyspnoea, a sensation of breathlessness, is reported by patients treated with ticagrelor. In PLATO, d
Eintrag öffnenBrilique · 4.8 · Dyspnoea Dyspnoea, a sensation of breathlessness, is reported by patients treated with ticagrelor. In PLATO, d
Eintrag öffnenBrilique · 4.8 · Dyspnoea Dyspnoea, a sensation of breathlessness, is reported by patients treated with ticagrelor. In PLATO, d
Eintrag öffnenBrilique · 4.8 · In PEGASUS, TIMI Major bleeding for ticagrelor 60 mg twice daily was higher than for ASA alone. No increased b
Eintrag öffnenBrilique · 4.8 · In PEGASUS, TIMI Major bleeding for ticagrelor 60 mg twice daily was higher than for ASA alone. No increased b
Eintrag öffnenBrilique · 4.8 · In PEGASUS, TIMI Major bleeding for ticagrelor 60 mg twice daily was higher than for ASA alone. No increased b
Eintrag öffnenBrilique · 4.8 · In PEGASUS, dyspnoea was reported in 14.2% of patients taking ticagrelor 60 mg twice daily and in 5.5% of pati
Eintrag öffnenBrilique · 4.8 · In PEGASUS, dyspnoea was reported in 14.2% of patients taking ticagrelor 60 mg twice daily and in 5.5% of pati
Eintrag öffnenBrilique · 4.8 · In PEGASUS, dyspnoea was reported in 14.2% of patients taking ticagrelor 60 mg twice daily and in 5.5% of pati
Eintrag öffnenBrilique · 4.8 · In PLATO, patients on ticagrelor had a higher incidence of discontinuation due to adverse events than clopidog
Eintrag öffnenBrilique · 4.8 · In PLATO, patients on ticagrelor had a higher incidence of discontinuation due to adverse events than clopidog
Eintrag öffnenBrilique · 4.8 · In PLATO, patients on ticagrelor had a higher incidence of discontinuation due to adverse events than clopidog
Eintrag öffnenBrilique · 4.8 · Intracranial bleeding: Spontaneous ICHs were reported in similar rates for ticagrelor 60 mg and ASA therapy al
Eintrag öffnenBrilique · 4.8 · Intracranial bleeding: Spontaneous ICHs were reported in similar rates for ticagrelor 60 mg and ASA therapy al
Eintrag öffnenBrilique · 4.8 · Intracranial bleeding: Spontaneous ICHs were reported in similar rates for ticagrelor 60 mg and ASA therapy al
Eintrag öffnenBrilique · 4.8 · Intracranial bleeding: There were more intracranial non-procedural bleeds with ticagrelor (n=27 bleeds in 26 p
Eintrag öffnenBrilique · 4.8 · Intracranial bleeding: There were more intracranial non-procedural bleeds with ticagrelor (n=27 bleeds in 26 p
Eintrag öffnenBrilique · 4.8 · Intracranial bleeding: There were more intracranial non-procedural bleeds with ticagrelor (n=27 bleeds in 26 p
Eintrag öffnen